Valproic acid (Depakene). A new anticonvulsant agent

Area of Science:

• Neurology
• Pharmacology

Background:

• Valproic acid is an anticonvulsant medication.
• Epilepsy encompasses various seizure types, including absence, tonic-clonic, and myoclonic seizures.

Purpose of the Study:

• To evaluate the efficacy and adverse effects of valproic acid in treating different epilepsy types.
• To determine valproic acid's utility as monotherapy or adjunct therapy.

Main Methods:

• Clinical assessment of patient responses to valproic acid.
• Monitoring of adverse reactions and treatment outcomes.

Main Results:

• Valproic acid demonstrates high efficacy in absence seizures (simple and complex).
• Improvement observed in tonic-clonic seizures, mixed absence with tonic-clonic seizures, and myoclonic epilepsy.
• Valproic acid is effective alone or as an adjunct, potentially reducing dosages of other anticonvulsants.
• Some patients refractory to other treatments respond to valproic acid.

Conclusions:

• Valproic acid is a versatile and effective anticonvulsant for a broad spectrum of epilepsy.
• Adverse reactions, primarily gastrointestinal issues and drowsiness, occur in about 20% of patients but are typically transient.
• Valproic acid offers a valuable treatment option, even for patients resistant to other antiepileptic drugs.